Skip to content
  • fr_FR
GD Avocats
  • Home
  • LAWFIRM
    • Presentation
    • Expertise
    • Team
  • News
  • Club PLFSS
    • Club PLFSS presentation
  • Contact
Menu Close

News

Read more about the article Health products pricing : clarification of the “industrial criterion”

Health products pricing : clarification of the “industrial criterion”

In a context of increasing supply tensions and stock-outs, the Social Security Financing Act ("LFSS") for…

Continue ReadingHealth products pricing : clarification of the “industrial criterion”
  • Post published:24/02/2023
  • Post category:News
Read more about the article PLFSS: medical devices soon to be substitutable by pharmacists

PLFSS: medical devices soon to be substitutable by pharmacists

Article 31 bis of the Social Security Financing Bill (PLFSS) for 2023 provides for the possibility…

Continue ReadingPLFSS: medical devices soon to be substitutable by pharmacists
  • Post published:22/11/2022
  • Post category:News
Read more about the article PLFSS: Creation of a specific financing method for advanced therapy medicinal products

PLFSS: Creation of a specific financing method for advanced therapy medicinal products

The Social Security Financing Bill (PLFSS) for 2023, adopted today in first reading by the Senate,…

Continue ReadingPLFSS: Creation of a specific financing method for advanced therapy medicinal products
  • Post published:15/11/2022
  • Post category:News
Read more about the article PLFSS: New rebates for manufacturers who apply for reimbursement in a limited number of indications

PLFSS: New rebates for manufacturers who apply for reimbursement in a limited number of indications

The examination of the Social Security Financing Bill (PLFSS) for 2023 by the deputies began today.…

Continue ReadingPLFSS: New rebates for manufacturers who apply for reimbursement in a limited number of indications
  • Post published:24/10/2022
  • Post category:News
Read more about the article Biosimilars: the Council of State clarifies the notion of prescription efficiency

Biosimilars: the Council of State clarifies the notion of prescription efficiency

Let us recall that an experimental incentive mechanism was introduced on the basis of Article 51…

Continue ReadingBiosimilars: the Council of State clarifies the notion of prescription efficiency
  • Post published:04/08/2022
  • Post category:News
Read more about the article Real life studies: call for census from the HAS

Real life studies: call for census from the HAS

The collection of real-life data[1] is a central issue for the evaluation of medicinal products and medical…

Continue ReadingReal life studies: call for census from the HAS
  • Post published:08/06/2022
  • Post category:News
Read more about the article Reimbursement of innovative medicinal products : the new criterion of relative therapeutic value

Reimbursement of innovative medicinal products : the new criterion of relative therapeutic value

Introduced in the Senate on November 25, 2021, the bill on health innovation aims to improve…

Continue ReadingReimbursement of innovative medicinal products : the new criterion of relative therapeutic value
  • Post published:17/05/2022
  • Post category:News
Read more about the article “Anti-gift” scheme: figures for the year 2021
man reject gift

“Anti-gift” scheme: figures for the year 2021

The French National Medical Council has published its annual report for the year 2021, in which…

Continue Reading“Anti-gift” scheme: figures for the year 2021
  • Post published:11/05/2022
  • Post category:News
Read more about the article Can a medicinal product be required to be treated identically to other specialties?

Can a medicinal product be required to be treated identically to other specialties?

The principle of equality requires the administration to settle identical situations in an identical manner[1]. In a…

Continue ReadingCan a medicinal product be required to be treated identically to other specialties?
  • Post published:26/04/2022
  • Post category:News
  • 1
  • 2
  • 3
  • Go to the next page

RECEIVE OUR NEWSLETTER







Legal notice — Privacy policy — Some cookies ensure the proper functioning of this website. No advertising cracking cookies are used. In accordance with the amended French Data Protection Act, you have the right to access, rectify and delete data concerning you.


Realization Anamorphik
Close Menu